[Federal Register Volume 85, Number 239 (Friday, December 11, 2020)]
[Notices]
[Page 80159]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-27240]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-748]


Bulk Manufacturer of Controlled Substances Application: Sterling 
Pharma USA, LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Sterling Pharma USA, LLC has applied to be registered as a 
bulk manufacturer of basic class(es) of controlled substance(s). Refer 
to Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before February 9, 
2021. Such persons may also file a written request for a hearing on the 
application on or before February 9, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on August 24, 2020, Sterling Pharma USA, LLC, 1001 
Sheldon Drive, Suite 101, Cary, North Carolina 27513-2079, applied to 
be registered as a bulk manufacturer of the following basic class(es) 
of controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols..................     7370  I
------------------------------------------------------------------------

    The company plans to manufacture in bulk drug code 7370 
(Tetrahydrocannabinols) exclusively from hemp extract, for distribution 
and sale to its customers. No other activities for this drug code is 
authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-27240 Filed 12-10-20; 8:45 am]
BILLING CODE 4410-09-P